Rituximab or Cyclosporine for Membranous Nephropathy. Reply

Fernando C. Fervenza; Daniel C. Cattran

doi:10.1056/NEJMc1910393

Rituximab or Cyclosporine for Membranous Nephropathy. Reply

Fernando C. Fervenza, Daniel C. Cattran

Nephrology and Hypertension

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	1689-1690
Number of pages	2
Journal	The New England journal of medicine
Volume	381
Issue number	17
DOIs	https://doi.org/10.1056/NEJMc1910393
State	Published - Oct 24 2019

ASJC Scopus subject areas

General Medicine

Access to Document

10.1056/NEJMc1910393

Cite this

@article{75794b7094b54f868711a6d31cf6d61d,

title = "Rituximab or Cyclosporine for Membranous Nephropathy. Reply",

author = "Fervenza, {Fernando C.} and Cattran, {Daniel C.}",

year = "2019",

month = oct,

day = "24",

doi = "10.1056/NEJMc1910393",

language = "English (US)",

volume = "381",

pages = "1689--1690",

journal = "The New England journal of medicine",

issn = "1533-4406",

publisher = "Massachussetts Medical Society",

number = "17",

}

TY - JOUR

T1 - Rituximab or Cyclosporine for Membranous Nephropathy. Reply

AU - Fervenza, Fernando C.

AU - Cattran, Daniel C.

PY - 2019/10/24

Y1 - 2019/10/24

UR - http://www.scopus.com/inward/record.url?scp=85074093572&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85074093572&partnerID=8YFLogxK

U2 - 10.1056/NEJMc1910393

DO - 10.1056/NEJMc1910393

M3 - Letter

C2 - 31644857

AN - SCOPUS:85074093572

SN - 1533-4406

VL - 381

SP - 1689

EP - 1690

JO - The New England journal of medicine

JF - The New England journal of medicine

IS - 17

ER -

Rituximab or Cyclosporine for Membranous Nephropathy. Reply

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this